D-0533-2026 Class III Ongoing

Recalled by Lannett Company Inc. — Seymour, IN

FDA drug recall D-0533-2026 was initiated by Lannett Company Inc. on Apr 24, 2026 and is designated Class III. Reason for recall: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. The recall status is ongoing. Affected quantity: 44865 bottles.

Recall details

Product Type
Drugs
Report Date
May 27, 2026
Initiation Date
Apr 24, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44865 bottles

Product description

Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01.

Reason for recall

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Distribution pattern

USA Nationwide

Code information

Lot#: 25283038A, Exp 1/31/2028; 25283564A, 25283565A, Exp 3/31/2028; 25285712A Exp 08/31/2028; 25284105A, Exp 4/30/2028; 25284874A, 25284875A, Exp 08/31/2028.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0533-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0533-2026. Report a data issue: hello@regdatalab.com.